Reich K, Simpson E, Wollenberg A, Bissonnette R, et al. Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3. Br J Dermatol 2023;188:208-217.
PMID: 36763879